Skip to main content
Clinical Trials/NCT03864718
NCT03864718
Completed
Not Applicable

Efficacy of Photodynamic Therapy and Intra-lesional 5-wing in Complex Perianal Fistula

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana0 sites49 target enrollmentJanuary 2016
ConditionsRectal Fistula

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Rectal Fistula
Sponsor
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Enrollment
49
Primary Endpoint
Healing
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Objective: Validate and analyze the results of intralesional photodynamic therapy in the treatment of complex anal fistula.

Methods: Prospective observational study including patients treated for complex anal fistula who underwent intralesional photodynamic therapy (i-PDT). Patients were included with a minimum follow up of 1-year, in order to evaluate recurrence, continence and postoperative morbidity. Intralesional 5-aminolevulinic acid gel 2% was directly injected into the fistula. The internal and external orifices were closed. After an incubation period of 2 h, the fistula was irradiated using an optical fibre connected to a red laser (MULTIDIODE 630 PDT, INTERmedic, Spain) operating at 1 W/ cm for 3 min (180 Joules).

Registry
clinicaltrials.gov
Start Date
January 2016
End Date
December 2018
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Responsible Party
Principal Investigator
Principal Investigator

Antonio Arroyo Sebastian

Principal Investigator

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Eligibility Criteria

Inclusion Criteria

  • complex anal fistula according to Parks classification

Exclusion Criteria

  • Non cryptoglandular fistulas
  • acute sepsis
  • inflammatory bowel diseases
  • simple fistulas (defined as subcutaneous, intersphincteric and low transsphincteric fistula)
  • pregnant patients
  • patients \<18
  • immunocompromised
  • patients who refused consent.

Outcomes

Primary Outcomes

Healing

Time Frame: 12 months after surgery

Yes/Not

Similar Trials